New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Alzheimer's disease can be diagnosed before symptoms emerge

Alzheimer's disease can be diagnosed before symptoms emerge

by Lund UniversityNIA-AA versus IWG criteria. Differences in the nomenclature of cognitively unimpaired individuals with (+) or without (−) in vivo biomarker evidence of Aβ (A) and tau (T) pathol
Neurology April 10,2024
Alzheimer's disease can be diagnosed before symptoms emerge

Alzheimer's disease can be diagnosed before symptoms emerge

by Lund UniversityNIA-AA versus IWG criteria. Differences in the nomenclature of cognitively unimpaired individuals with (+) or without (−) in vivo biomarker evidence of Aβ (A) and tau (T) pathol
Neurology April 10,2024
Alzheimer's disease destroys neurons that keep us awake

Alzheimer's disease destroys neurons that keep us awake

by University of California, San FranciscoCredit: CC0 Public DomainResearchers and caregivers have noted that excessive daytime napping can develop long before the memory problems associated with
Neurology April 10,2024
Alzheimer's disease destroys neurons that keep us awake

Alzheimer's disease destroys neurons that keep us awake

by University of California, San FranciscoCredit: CC0 Public DomainResearchers and caregivers have noted that excessive daytime napping can develop long before the memory problems associated with
Neurology April 10,2024
COVID-19 immunity may last six months or more

COVID-19 immunity may last six months or more

by Meghan Rosen,Howard Hughes Medical InstituteScientists found traces of SARS-CoV-2 (green) in cells lining people’s intestines three months after infection. Antibodies may evolve in response t
Immunology & Rheumatology April 10,2024
COVID-19 immunity may last six months or more

COVID-19 immunity may last six months or more

by Meghan Rosen,Howard Hughes Medical InstituteScientists found traces of SARS-CoV-2 (green) in cells lining people’s intestines three months after infection. Antibodies may evolve in response t
Immunology & Rheumatology April 10,2024
COVID-19 unmasked: Math model suggests optimal treatment strategies

COVID-19 unmasked: Math model suggests optimal treatment strategies

by Massachusetts General HospitalColorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Ima
Immunology & Rheumatology April 10,2024
COVID-19 unmasked: Math model suggests optimal treatment strategies

COVID-19 unmasked: Math model suggests optimal treatment strategies

by Massachusetts General HospitalColorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Ima
Immunology & Rheumatology April 10,2024
COVID-19 : Measuring viral RNA to predict which patients will die

COVID-19 : Measuring viral RNA to predict which patients will die

by University of MontrealColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIAI
Immunology & Rheumatology April 10,2024
COVID-19 : Measuring viral RNA to predict which patients will die

COVID-19 : Measuring viral RNA to predict which patients will die

by University of MontrealColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIAI
Immunology & Rheumatology April 10,2024
COVID-19 model reveals key role for innate immunity in controlling viral load

COVID-19 model reveals key role for innate immunity in controlling viral load

by American Chemical SocietyColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the N
Immunology & Rheumatology April 10,2024
COVID-19 model reveals key role for innate immunity in controlling viral load

COVID-19 model reveals key role for innate immunity in controlling viral load

by American Chemical SocietyColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the N
Immunology & Rheumatology April 10,2024
COVID-19 virus helps block host immunity

COVID-19 virus helps block host immunity

by Mary Ann Liebert, IncSARS-CoV-2 (shown here in an electron microscopy image). Credit: National Institute of Allergy and Infectious Diseases, NIHSARS-CoV-2, the virus that causes COVID-19, bloc
Immunology & Rheumatology April 10,2024
COVID-19 virus helps block host immunity

COVID-19 virus helps block host immunity

by Mary Ann Liebert, IncSARS-CoV-2 (shown here in an electron microscopy image). Credit: National Institute of Allergy and Infectious Diseases, NIHSARS-CoV-2, the virus that causes COVID-19, bloc
Immunology & Rheumatology April 10,2024
SARS-CoV-2 antibodies detectable up to seven months post COVID-19 onset

SARS-CoV-2 antibodies detectable up to seven months post COVID-19 onset

by Instituto de Medicina MolecularColorized scanning electron micrograph of a dying cell (blue) heavily infected with SARS-CoV-2 (yellow), the virus that causes COVID-19. Credit: NIAID Integrated Rese
Immunology & Rheumatology April 10,2024
SARS-CoV-2 antibodies detectable up to seven months post COVID-19 onset

SARS-CoV-2 antibodies detectable up to seven months post COVID-19 onset

by Instituto de Medicina MolecularColorized scanning electron micrograph of a dying cell (blue) heavily infected with SARS-CoV-2 (yellow), the virus that causes COVID-19. Credit: NIAID Integrated Rese
Immunology & Rheumatology April 10,2024
COVID-19 science: Understanding the basics of 'herd immunity'

COVID-19 science: Understanding the basics of 'herd immunity'

by Dr. Eduardo Sanchez,American Heart AssociationCredit: CC0 Public DomainRecently I heard a medical "expert" on the news incorrectly define the term "herd immunity." It'
Immunology & Rheumatology April 10,2024
COVID-19 science: Understanding the basics of 'herd immunity'

COVID-19 science: Understanding the basics of 'herd immunity'

by Dr. Eduardo Sanchez,American Heart AssociationCredit: CC0 Public DomainRecently I heard a medical "expert" on the news incorrectly define the term "herd immunity." It'
Immunology & Rheumatology April 10,2024
COVID-19 virus rapidly evolves to higher infectivity during in vitro growth, which may be a step toward lower virulence

COVID-19 virus rapidly evolves to higher infectivity during in vitro growth, which may be a step toward lower virulence

by Jeff Hansen,University of Alabama at BirminghamCredit: Pixabay/CC0 Public DomainViruses accumulate mutations as they replicate in infected cells. Repeated replication can lead to viral strain
Immunology & Rheumatology April 10,2024
COVID-19 virus rapidly evolves to higher infectivity during in vitro growth, which may be a step toward lower virulence

COVID-19 virus rapidly evolves to higher infectivity during in vitro growth, which may be a step toward lower virulence

by Jeff Hansen,University of Alabama at BirminghamCredit: Pixabay/CC0 Public DomainViruses accumulate mutations as they replicate in infected cells. Repeated replication can lead to viral strain
Immunology & Rheumatology April 10,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com